Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 34,791 | 41,764 | N/A | N/A |
| TOTAL | $36,445 | $42,379 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 5,659 | 1,640 | N/A | N/A |
| Investments And Advances | 166 | 0 | 0 | 0 |
| Other Non-Current Assets | 7,468 | 5,364 | 0 | 0 |
| TOTAL | $13,293 | $7,004 | $N/A | $N/A |
| Total Assets | $49,738 | $49,383 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 2,910 | 1,010 | 0 | 0 |
| Accrued Expenses | 2,494 | 943 | N/A | N/A |
| TOTAL | $17,446 | $2,396 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 10,627 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 65,938 | 64,125 | 0 | 0 |
| TOTAL | $74,754 | $64,125 | $N/A | $N/A |
| Total Liabilities | $92,200 | $66,521 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | N/A | N/A | N/A |
| Retained earnings | -43,533 | -17,406 | N/A | N/A |
| TOTAL | $-42,462 | $-17,138 | $N/A | $N/A |
| Total Liabilities And Equity | $49,738 | $49,383 | $0 | $0 |